Chinese investment firm Shanghai Jiuchuan has just acquired SHL Telemedicine, a SIX Swiss Exchange listed firm that develops and markets advanced personal telemedicine solutions, for $120 million.
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. Shanghai Jiuchuan Investment is a Shanghai based private investment firm and is controlled by Rengao Qian, Jianfang Cheng and An Yong Tianjin Investment.
To see a list of investors from China similar to Shanghai Jiuchuan, check the Chinese Investors Directory
More details follows